Summary:
The purpose of this study is to evaluate the clinical efficacy and safety of study drug WC2031 200 mg tabs taken once a day for 7 days vs Vibramycin 100 mg capsules taken twice a day for 7 days, for treatment of uncomplicated urogenital Chlamydia.
Qualified Participants Must:
• Be 19-45 years of age
•
Have self/partner diagnosed with Chlamydia
•
Be willing to abstain from alcohol during treatment period
•
Be willing to abstain from sexual activity or use condoms during trial
Qualified Participants May Receive:
Study related care, study medication, lab work and reimbursement for time and travel.